Rheumatoid arthritis clinical trials

Explore recruiting rheumatoid arthritis clinical trials.

Recruiting rheumatoid arthritis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rheumatoid arthritis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Filling bone erosions: a longitudinal multicentric HR-pQCT study of subcutaneous tocilizumab in rheumatoid arthritis

France

Therapeutic use (Phase IV) EU CTIS Study details

DISCO-RA:DIScontinuation of COncomitant disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis patients also using TNF inhibitors - a randomized long-term non-inferiority strategy trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Immune-Related Rheumatological and neurological Adverse Events study (IRRAE study)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-Guided Dose Reduction in Patients with Rheumatoid Arthritis: The RITUXERA Trial.

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

The effect of Janus Kinase inhibitors on the heart in Rheumatoid Arthrtis

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

J3P-MC-FTAF: An Adaptive Phase 2a/2b, Randomized, Double-Blind, Placebo-Controlled Study of LY3871801 in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis

France, Czechia, Slovakia, Germany, Hungary, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Rheumatoid arthritis trials by city

Rheumatoid arthritis clinical trials

Recruiting rheumatoid arthritis studies right now

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Stand UP to Rheumatoid Arthritis (SUPRA)

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis

Investigating the Effects of the Digital App Rheumabuddy4.1 in a Clinical RCT Set-up in Patients With Rheumatoid Arthritis

Effect of Mediterranean vs Paleolithic Diet on RA Activity, Sarcopenia and QOL: 12-Week RCT

A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)

Also recruiting in Europe

Filling bone erosions: a longitudinal multicentric HR-pQCT study of subcutaneous tocilizumab in rheumatoid arthritis

DISCO-RA:DIScontinuation of COncomitant disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis patients also using TNF inhibitors - a randomized long-term non-inferiority strategy trial

Immune-Related Rheumatological and neurological Adverse Events study (IRRAE study)

Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-Guided Dose Reduction in Patients with Rheumatoid Arthritis: The RITUXERA Trial.

The effect of Janus Kinase inhibitors on the heart in Rheumatoid Arthrtis

J3P-MC-FTAF: An Adaptive Phase 2a/2b, Randomized, Double-Blind, Placebo-Controlled Study of LY3871801 in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis

Rheumatoid arthritis trials by city

Other conditions